Press Releases

Our press releases

• Bio-Path Holdings Presents Preclinical Data at American Association for Cancer Research Annual Meeting 2019 — Highlighting Important Cancer Gene, STAT3, Therapeutic Strategy in Pancreatic, Non-Small Cell Lung Cancers and Acute Myelogenous Leukemia Apr 3 2019
• BIO-PATH HOLDINGS REPORTS FULL YEAR 2018 FINANCIAL RESULTS: Conference Call to be Held Today at 8:30 a.m. ET Mar 20 2019
• Bio-Path Holdings to Announce Fourth Quarter and Full Year 2018 Financial Results on March 20, 2019 Mar 15 2019
• Bio-Bio-Path Holdings, Inc. Announces Closing of $18.5 Million Registered Direct Offering of Common Stock Mar 14 2019
• Bio-Path Holdings, Inc. Announces $18.5 Million Registered Direct Offering of Common Stock Mar 12 2019
• Bio-Path Announces Clinical Update to Interim Analysis of Phase 2 Prexigebersen Trial in Acute Myeloid Leukemia Mar 6 2019
• Bio-Path Holdings to Present Data at the 2019 AACR Annual Meeting Feb 28 2019
• Bio-Path Holdings, Inc. Announces Closing of $1.7 Million Registered Direct Offering Priced At-the-Market Jan 23 2019
• Bio-Path Holdings, Inc. Announces $1.7 Million Registered Direct Offering Priced At-the-Market Jan 18 2019
• Bio-Path Holdings Announces 1-for-20 Reverse Stock Split Jan 18 2019